XCUR

Exicure, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website exicuretx.com
Employees(FY) 7
ISIN US30205M3097

Performance

+247.52%

+317.54%

+466.01%

+351.66%

+285.66%

YTD

+302.88%

Profile

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Advanced Technical Analysis

Technical Analysis of XCUR 2024-11-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 76 further supports this positive outlook. However, the Oscillators Score of 56 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of XCUR

Stock Rank

Recent News & Updates

2024-11-14 03:01
Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results(Businesswire)
2024-09-18 04:01
Exicure, Inc. Receives Extension from Nasdaq Hearings Panel(Businesswire)
2024-09-09 06:53
Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation(Yahoo Finance)
2024-08-25 21:08
Exicure, Inc. Announces 1-for-5 Reverse Stock Split(Businesswire)
2024-08-18 22:31
Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting(Businesswire)
2024-08-14 22:31
Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting(Businesswire)
2024-08-13 04:01
Exicure, Inc. Reports Second Quarter 2024 Financial Results(Businesswire)
2024-08-08 04:27
Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics(Businesswire)
2024-08-01 19:34
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-08-01 04:01
Exicure, Inc. Receives Positive Listing Determination from Nasdaq(Businesswire)
2024-07-25 19:36
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-06-17 09:53
XCUR Stock Earnings: Exicure Reported Results for Q1 2024(Investorplace)
2024-06-17 04:01
Exicure, Inc. Reports First Quarter 2024 Financial Results(Businesswire)
2024-06-06 09:52
XCUR Stock Earnings: Exicure Reported Results for Q4 2023(Investorplace)
2024-06-06 04:01
Exicure, Inc. Reports Full Year 2023 Financial Results(Businesswire)
2024-05-28 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-23 04:01
Exicure, Inc. Received Nasdaq Notice of a Delisting Determination(Businesswire)
2024-05-16 09:52
XCUR Stock Earnings: Exicure Reported Results for Q3 2023(Investorplace)
2024-05-16 04:08
Exicure, Inc. Reports Third Quarter 2023 Financial Results(Businesswire)
2024-04-22 04:01
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K(Businesswire)
2024-02-05 18:05
Exicure and Bluejay sign hepatitis treatment development deal(Pharmaceutical-business-review)
2024-02-05 03:01
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis(Businesswire)
2023-12-07 19:40
Why Is Exicure (XCUR) Stock Up 57% Today?(Investorplace)
2023-11-28 03:01
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q(Businesswire)
2023-08-22 21:48
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors(Yahoo Finance)
2023-08-11 04:01
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update(Yahoo Finance)
2023-07-14 04:01
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update(Yahoo Finance)
2023-05-26 04:01
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives(Yahoo Finance)
2023-05-19 04:01
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q(Yahoo Finance)
2023-05-04 04:01
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.